Therapeutic Plasma Exchange for COVID-19-Associated Hyperviscosity.

CONCLUSIONS: This series demonstrates the utility of TPE to rapidly correct increased blood viscosity in patients with COVID-19-associated hyperviscosity. Large randomized trials are needed to determine whether TPE may improve clinical outcomes for patients with COVID-19.
PMID: 33231313 [PubMed - as supplied by publisher]

Source: Transfusion - November 24, 2020 Category: Hematology Authors: Truong AD, Auld SC, Barker NA, Friend S, Wynn AT, Cobb J, Sniecinski RM, Tanksley CL, Polly DM, Gaddh M, Connor M, Nakahara H, Sullivan HC, Kempton C, Guarner J, Duncan A, Josephson CD, Roback JD, Stowell SR, Maier CL Tags: Transfusion Source Type: research